Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors-Reference-Cited by-同舟云学术

Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors

Published:2015-05-13 Issue:8 Volume:5 Page:850-859
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Frampton Garrett M.,Ali Siraj M.,Rosenzweig Mark,Chmielecki Juliann,Lu Xinyuan,Bauer Todd M.,Akimov Mikhail,Bufill Jose A.,Lee Carrie,Jentz David,Hoover Rick,Ou Sai-Hong Ignatius,Salgia Ravi,Brennan Tim,Chalmers Zachary R.,Jaeger Savina,Huang Alan,Elvin Julia A.,Erlich Rachel,Fichtenholtz Alex,Gowen Kyle A.,Greenbowe Joel,Johnson Adrienne,Khaira Depinder,McMahon Caitlin,Sanford Eric M.,Roels Steven,White Jared,Greshock Joel,Schlegel Robert,Lipson Doron,Yelensky Roman,Morosini Deborah,Ross Jeffrey S.,Collisson Eric,Peters Malte,Stephens Philip J.,Miller Vincent A.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 647 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology;Lung Cancer;2024-10

2. Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study;Lung Cancer;2024-10

3. Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain;eLife;2024-09-13

4. Precision oncology: current and future platforms for treatment selection;Trends in Cancer;2024-09

5. MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database;ESMO Open;2024-09